Utilization of the BIOWAVE Device to Treat Overactive Bladder

Completed · Not applicable

Conditions studied: Overactive Bladder

In brief

Demonstrate a response to stimulation of the posterior tibial nerve using the Biowave device and a microneedle patch electrode in patients with overactive bladder symptoms. The investigators hypothesize that after at least 6 weekly treatments there will be modest improvements in overactive bladder symptoms trending toward more improvement.

Key facts

Study ID

NCT01848366

Run by

Kenneth Peters, MD

People needed

8

Starts

2013-05-01

Expected to finish

2014-08-01

Last updated by the study team

2016-12-07

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women >18 years of age
• A score of > 4 on the OAB-q short form for urgency (question 1)
• Average daily urinary frequency > 10 times based on a 3-day voiding diary
• Self-reported bladder symptoms present > 3 months
• Self-reported failed conservative care (i.e., dietary restriction, fluid restriction, bladder training, behavioral modification, pelvic muscle training, biofeedback, etc.)
• Off all antimuscarinics for at least 2 weeks prior to enrollment
• Capable of giving informed consent
• Ambulatory and able to use a toilet independently, without difficulty
• Capable and willing to follow all study-related procedures

You may not qualify if…

• Pregnant as confirmed by urine pregnancy test, or plans to become pregnant during the study period
• Neurogenic bladder
• Botox® use in bladder or pelvic floor muscles in the past year
• Pacemakers or implantable defibrillators
• Primary complaint of stress urinary incontinence
• Current urinary tract infection (UTI)
• Current vaginal infection
• Current use of InterStim®
• Current use of Bion®
• Previously been treated with Percutaneous Tibial Nerve Stimulation (PTNS)
• Use of investigational drug/device therapy within the past 4 weeks.
• Participating or have participated within the past 4 weeks in any clinical investigation involving or impacting gynecologic, urinary or renal function.
• Deemed unsuitable for enrollment in study by the investigators based on subjects' history or physical examination (including skin disorders at the treatment site or peripheral neuropathy).
• Subjects with nerve damage that would impact either percutaneous tibial nerve or pelvic floor function.

Where it is running

• William Beaumont Hospital — Royal Oak, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.